T-Cell Landscape in a Primary Melanoma Predicts the Survival of Patients With Metastatic Disease After Their Treatment With Dendritic Cell Vaccines

Cancer Research - United States
doi 10.1158/0008-5472.can-15-3211
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

T Cell Landscape Within Primary Melanoma as a Biomarker of Survival After Cancer Vaccination in Patients With Metastatic Disease

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

CD8+ T Cell Responses in Metastatic Melanoma Patients Receiving an Adenovirally Antigen Engineered Dendritic Cell Vaccine +/- IFN-α

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

A Three-Variable Model Predicts Short Survival in Patients With Newly Diagnosed Metastatic Renal Cell Carcinoma

Journal of Clinical Medicine Research
2017English

Improved Survival With T Cell Clonotype Stability After Anti-Ctla-4 Treatment in Cancer Patients

Science Translational Medicine
Medicine
2014English

Long-Term Survival of Pancreatic Cancer Patients Treated With Multimodal Therapy Combined With WT1-targeted Dendritic Cell Vaccines

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2018English

Immunotherapy of Cancer With Dendritic Cell-Based Vaccines

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
1998English

Twelve-Year Survival and Immune Correlates in Dendritic Cell–vaccinated Melanoma Patients

JCI insight
Medicine
2017English

Influence of Metronomic Cyclophosphamide and Interleukine-2 Alone or Combined on Blood Regulatory T Cells in Patients With Advanced Malignant Melanoma Treated With Dendritic Cell Vaccines

Journal of Clinical & Cellular Immunology
2012English

Enhanced Survival in Patients With Multiple Primary Melanoma

Archives of Dermatology
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy